ArticleACS environmental Au2025
Speciation and Thermodynamic Study of Arsenic(III)-Pharmaceutical Complexes in Aqueous Solutions.
Article in ACS environmental Au, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNatural water sources are increasingly contaminated with a wide range of pollutants including heavy metals and pharmaceuticals. Arsenic, particularly in its more toxic trivalent form, i.e. As-(III), remains a significant environmental and public health concern due to its widespread presence and carcinogenic effects. In addition to that, pharmaceutical products like metronidazole (MNZ) and nalidixic acid (NAL), persistent in the environment due to their limited biodegradability, also pose significant threats to both ecosystems and human health. Recent research has highlighted the formation of antibiotic-metal complexes (AMCs) where antibiotics interact with heavy metals in aquatic environments, leading to altered physicochemical properties and increased toxicity.
aimThe main objective of the present work is a speciation study on As-(III)-antibiotic complexes and particularly interaction between As-(III) and MNZ or NAL in aqueous solution.
methodsSeveral temperatures and ionic strengths were probed by potentiometry to determine the formation constants and other thermodynamic parameters of As-(III)-MNZ and As-(III)-NAL complexes. UV spectrophotometric titrations were also employed to confirm formation constants of both systems. An estimation of the sequestering ability of both ligands toward As-(III) under relevant natural water conditions has also been performed. Further, density functional theory calculations have been executed with the purpose of investigating the molecular structure of these complexes and their relative stability.
resultsIt turns out that MNZ binds to As-(III) in either a neutral (AsMNZ) or protonated (As-(MNZ)-H) form via As-N and As-O interactions, with the hydroxyl oxygen being the preferred binding site in AsMNZ and both the nitro and hydroxyl groups being equally effective in As-(MNZ)-H, while NAL forms a stable chelated complex through bidentate coordination.
conclusionFindings reported in this study contribute to a deeper understanding of the complexes formed by As-(III) with pharmaceuticals and pave the way toward the development of improved technologies for the water treatment and remediation of AMCs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.